Celecoxib Sandoz 100 mg kapseli, kova Suomi - suomi - Fimea (Suomen lääkevirasto)

celecoxib sandoz 100 mg kapseli, kova

sandoz a/s - celecoxib - kapseli, kova - 100 mg - selekoksibi

Celecoxib Sandoz 200 mg kapseli, kova Suomi - suomi - Fimea (Suomen lääkevirasto)

celecoxib sandoz 200 mg kapseli, kova

sandoz a/s - celecoxib - kapseli, kova - 200 mg - selekoksibi

Celecoxib Krka 100 mg kapseli, kova Suomi - suomi - Fimea (Suomen lääkevirasto)

celecoxib krka 100 mg kapseli, kova

krka sverige ab - celecoxib - kapseli, kova - 100 mg - selekoksibi

Celecoxib Krka 200 mg kapseli, kova Suomi - suomi - Fimea (Suomen lääkevirasto)

celecoxib krka 200 mg kapseli, kova

krka sverige ab - celecoxib - kapseli, kova - 200 mg - selekoksibi

Celecoxib Viatris 100 mg kapseli, kova Suomi - suomi - Fimea (Suomen lääkevirasto)

celecoxib viatris 100 mg kapseli, kova

upjohn eesv - celecoxib - kapseli, kova - 100 mg - selekoksibi

Celecoxib Viatris 200 mg kapseli, kova Suomi - suomi - Fimea (Suomen lääkevirasto)

celecoxib viatris 200 mg kapseli, kova

upjohn eesv - celecoxib - kapseli, kova - 200 mg - selekoksibi

Celecoxib Stada 100 mg kapseli, kova Suomi - suomi - Fimea (Suomen lääkevirasto)

celecoxib stada 100 mg kapseli, kova

stada arzneimittel ag - celecoxib - kapseli, kova - 100 mg - selekoksibi

Celecoxib Stada 200 mg kapseli, kova Suomi - suomi - Fimea (Suomen lääkevirasto)

celecoxib stada 200 mg kapseli, kova

stada arzneimittel ag - celecoxib - kapseli, kova - 200 mg - selekoksibi

Clopidogrel Taw Pharma (previously Clopidogrel Mylan) Euroopan unioni - suomi - EMA (European Medicines Agency)

clopidogrel taw pharma (previously clopidogrel mylan)

taw pharma (ireland) limited - klopidogreelin hydrokloridi - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - antitromboottiset aineet - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:,    - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). ,     - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2  score ≥4) or minor is (nihss  ≤3) within 24 hours of either the tia or is event.  , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.

Silodosin Recordati Euroopan unioni - suomi - EMA (European Medicines Agency)

silodosin recordati

recordati ireland ltd - silodosiinilla - prostatic hyperplasia - urologicals, alfa-salpaajat - hoitoon oireiden ja eturauhasen hyvänlaatuisen liikakasvun (bph) hoitoon aikuisilla miehillä.